Results 251 to 260 of about 137,149 (293)

Multiphysics‐Driven Assembly of Biomimetic Vesicles

Advanced Materials, EarlyView.
Artificial extracellular vesicles, derived from cell membranes, are manufactured using a multiphysics‐integrated microfluidic platform that combines nanoknife membrane rupture, herringbone chaotic mixing, and acoustothermal modulation. This standardizable workflow enables the predictable control of vesicle formation and therapeutic loading, while ...
Timofei Solodko, Ian Gimino, Aastha Chandiwala, Bayan Alkotoub, Ali Bashiri Dezfouli, Heiko Reith, Asjad Bakhtiar, Rojda Hicsanmaz, Johann Brenner, Christoph J. O. Kaiser, Elena Belli, Shilpi Pandey, Samuel D. Rabkin, Kornelius Nielsch, Gabriele Multhoff, Oliver Hayden, Morteza Hasanzadeh Kafshgari   +16 more
wiley   +1 more source

Immunotherapy for Solid Tumours: Current Clinical Landscape and Future Directions.

Eur Surg Res
van Diepen AE, Kucukcelebi S, de Vos-Geelen J, Kooreman NG.   +3 more
europepmc   +1 more source

Serotonergic System‐Targeted Nucleic Acid Hydrogel Coordinates Excitability Restoration and Circuit Reconstruction for Spinal Cord Injury Therapy

Advanced Materials, EarlyView.
The study reports a DNA/RNA heteroduplex hydrogel (SeroPTEN‐CG) that undergoes DNase‐mediated hydrogel‐to‐nanogel transition for spinal cord injury therapy by targeting the serotonergic system, combining 5‐hydroxytryptamine (5‐HT)‐mediated excitability restoration to reactivate dormant interneurons with phosphatase and tensin homolog (PTEN)‐targeted ...
Chunlin Li, Xiaoqing Zhao, Kai Jiang, Haixia Kang, Shuo Liu, Linlin Jiang, Baoshuai Bai, Haonan Cui, Ziyang Zhang, Menglei Dong, Ruizhi Zhang, Chenbo Zou, Shenghui Shang, Chi Zhang, Xiangchuang Fan, Lijuan Zhu, Huiquan Duan, Chuan Zhang, Shiqing Feng, Hengxing Zhou   +19 more
wiley   +1 more source

Serum Onconeural Antibodies in Dogs and Cats for Early Diagnosis of Cancer. [PDF]

Vet Med (Auckl)
Agassandian M, Agassandian K.
europepmc   +1 more source

Reframing adjuvant immunotherapy in melanoma: all of it starts with priming. [PDF]

J Immunother Cancer
Ascierto PA, Melero I.
europepmc   +1 more source

High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years? [PDF]

J Immunother Cancer
Sondel PM, Rakhmilevich AL, Ansari IH, Erbe AK.   +3 more
europepmc   +1 more source

Cancer vaccines: advances, hurdles, and future directions. [PDF]

Explor Target Antitumor Ther
Vlachostergios PJ.
europepmc   +1 more source

Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients. [PDF]

Front Immunol
Brochier W, Nguyen S, Cesson V, Bricard O, van Baren N, Hames G, Dauguet N, Dano H, Tombal B, Rodrigues-Dias SC, Masnada A, Genolet R, Harari A, Roth B, Lucca I, Nardelli-Haefliger D, Coulie PG, Derré L.   +17 more
europepmc   +1 more source

[New antigens in human continuous cell lines and neoplasms].

Voprosy virusologii, 1975
V S, Korosteleva, R G, Pavliuchenkova, N P, Kosiakova, S A, Demidova, V M, Zhdanov   +4 more
openaire   +1 more source